Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00447863
Status:
WITHDRAWN
Last Update Posted:
2021-08-20
First Post:
2007-03-13
Brief Title:
Study Evaluating the Bioequivalence of LevonorgestrelEthinyl Estradiol Combinations in Cycling Women
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Open-Label Single-Dose Randomized 2-Period Crossover Bioequivalence Study to Compare Levonorgestrel 90 mgEthinyl Estradiol 20 mg in 2 Dosage Forms With Different Dissolution Characteristics in Healthy Cycling Women
Status:
WITHDRAWN
Status Verified Date:
2021-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Levonorgestrelethinyl estradiol LNGEE is an investigational drug that is being developed as an oral contraceptive birth control pill The purpose of this trial is to compare different preparations of LNGEE by assessing the way they are absorbed into the blood
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None